INCYTE CORP

INCY · Nasdaq · SIC 8731: Services-Commercial Physical & Biological Research · Market Cap: $19.5B · 2,844 employees
109
SEC Filings
$120.39
Close 2026-10-30
2,844
Employees

Business Summary

Incyte Corporation is a global biopharmaceutical company focused on discovery, development, and commercialization of proprietary therapeutics in three areas: Hematology, Oncology, and Inflammation and Autoimmunity (IAI). Its approved products include JAKAFI (ruxolitinib) for MF, PV, and GVHD; ICLUSIG (ponatinib) for CML and Ph+ ALL; MONJUVI/MINJUVI (tafasitamab) for DLBCL and FL; NIKTIMVO (axatilimab-csfr) for chronic GVHD; PEMAZYRE (pemigatinib) for cholangiocarcinoma; and ZYNYZ (retifanlimab-dlwr). Headquartered in Wilmington, Delaware, with European, Japanese, and Canadian offices.

Latest Stock Quote

INCY 2026-10-30 $120.39 O:$120.1 H:$122.8695 L:$119.55 Vol:2.8M VWAP:$120.5882
origin leaf: null

Next Earnings

expected 2026-11-30

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-102025-12-310000879169-26-000010EDGAR78K words
2025-02-102024-12-310001628280-25-004633EDGAR82K words
2024-02-132023-12-310000879169-24-000045EDGAR78K words
2023-02-072022-12-310000879169-23-000008EDGAR83K words
2022-02-082021-12-310001558370-22-000902EDGAR86K words
2021-02-092020-12-310001558370-21-000825EDGAR87K words
2020-02-132019-12-310001558370-20-000774EDGAR87K words
2019-02-142018-12-310001558370-19-000682EDGAR90K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-10-292026-09-300000879169-26-000066EDGAR49K words
2026-07-282026-06-300000879169-26-000056EDGAR48K words
2025-10-282025-09-300000879169-25-000118EDGAR51K words
2025-07-292025-06-300000879169-25-000103EDGAR54K words
2025-04-292025-03-310000879169-25-000056EDGAR50K words
2024-10-292024-09-300000879169-24-000172EDGAR53K words
2024-07-302024-06-300000879169-24-000149EDGAR52K words
2024-04-302024-03-310000879169-24-000077EDGAR48K words
2023-10-312023-09-300000879169-23-000041EDGAR55K words
2023-08-012023-06-300000879169-23-000025EDGAR55K words
2023-05-022023-03-310000879169-23-000016EDGAR51K words
2022-11-012022-09-300000879169-22-000010EDGAR55K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-130000879169-26-000068EDGAR1K words
2026-10-290000879169-26-000063EDGAR10K words
2026-08-310000879169-26-000058EDGAR1K words
2026-07-280000879169-26-000053EDGAR10K words
2026-03-300000879169-26-000018EDGAR1K words
2026-03-260000879169-26-000016EDGAR1K words
2026-03-060000879169-26-000013EDGAR1K words
2026-02-100000879169-26-000006EDGAR9K words
2025-12-120000879169-25-000122EDGAR0K words
2025-10-280000879169-25-000115EDGAR8K words

109 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ABSI — Absci Corp CRL — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CBIH — Cannabis Bioscience International Holdings, Inc. FOXO — FOXO TECHNOLOGIES INC. ICLR — ICON PLC IQV — IQVIA HOLDINGS INC. NOTV — Inotiv, Inc. MXCT — MAXCYTE, INC.

Tags

hematology oncology inflammation-and-autoimmunity myeloproliferative-neoplasms graft-versus-host-disease cholangiocarcinoma diffuse-large-b-cell-lymphoma follicular-lymphoma

Company Identity

CIK0000879169
TickerINCY
ExchangeNasdaq
SIC8731: Services-Commercial Physical & Biological Research
IncorporatedDE
HeadquartersWilmington, Delaware
Websitehttps://www.incyte.com
Listed1993-11-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: b2f050ad6cf935832dcfffe0e305c2fa8efe51d5a1cdb052c5945808bc8b4697
parent: 401ab5773be1d871db493032adc8ea971ec1a76c6c822f951590c4fda2c8e0c3
content hash: 54c042c89982cd9b718bdc26490f203f148672257a09a532011b1de9e79f4b98
signed: 2026-11-16T19:02:54.715Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INCY using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INCY, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INCY (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.